Link to Articles

Nov 01 2007, 12:20 PM EST
Merck Seals $136M Hep B Vaccine Pact with Dynavax
Heplisav is currently in Phase III trials. Full Story

Nov 01 2007, 12:14 PM EST
Averion Expands Clinical Research Services through $36.01M Acquisition of Hesperion
Firm will have offices in 10 countries and will approximately double its workforce. Full Story

Nov 01 2007, 12:17 PM EST
SAIC Obtains $32.7M Malaria Vaccine Production Support Contract Extension
Company will provide NIAID with R&D services and pilot-lot production for evaluation in clinical studies. Full Story

Oct 31 2007, 11:28 AM EST
Researchers Find New Role for Dopamine in Parkinson's Development
Acta Neuropathologica paper describes research showing that dopamine gets converted into DOPAL, which induces the death of dopamine-producing cells. Full Story

Oct 30 2007, 01:13 PM EST
Researchers Discover Memory in Cells that Influences Future Interactions
Georgia Tech team's finding, published in PNAS, could possibly invalidate previous cell research. Full Story

Oct 30 2007, 01:15 PM EST
Nycomed to Acquire Bradley for $346M
Purchase will strengthen dermatology focus. Full Story

Oct 30 2007, 01:08 PM EST
Taisho Poised to Receive $22M from Pfizer for Schizophrenia Candidate
If license agreement is signed, Pfizer will advance mGluR agonist outside of Japan. Full Story

Oct 30 2007, 01:10 PM EST
Lilly Obtains Portfolio of TRPV1 Molecules from Glenmark for $45M Upfront
Milestone fees related to advancement of lead candidate in osteoarthritic pain and other indications could reach $305 million. Full Story

Oct 30 2007, 01:01 PM EST
Beckman Coulter Steps Up Efforts for Molecular Diagnostic Development through JHU Deal
Licensing option pacts cover 200 genes linked to breast and colon cancers as well as IP linked to ongoing studies in six other cancers. Full Story

01/11/2007 - Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules.

Link to Article

In-Pharmatechnologist.com

01/11/2007 - For the first time, scientists have found a way to target viral antigens deep inside a cancer tumour, and the result is a new therapy that could treat or even prevent the disease.

Link to Article

DrugResearcher.com